Biomind Labs Inc. BMND.NE Stock
Biomind Labs Inc. Price Chart
Biomind Labs Inc. BMND.NE Financial and Trading Overview
| Biomind Labs Inc. stock price | 0.38 CAD |
| Previous Close | 0.5 CAD |
| Open | 0.42 CAD |
| Bid | 0.02 CAD x N/A |
| Ask | 0.49 CAD x N/A |
| Day's Range | 0.42 - 0.42 CAD |
| 52 Week Range | 0.16 - 1.4 CAD |
| Volume | 100 CAD |
| Avg. Volume | 2.01K CAD |
| Market Cap | 37.01M CAD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BMND.NE Valuation Measures
| Enterprise Value | 31.39M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -11.971 |
Trading Information
Biomind Labs Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -55.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.4 CAD |
| 52 Week Low | 0.16 CAD |
| 50-Day Moving Average | 0.54 CAD |
| 200-Day Moving Average | 0.77 CAD |
BMND.NE Share Statistics
| Avg. Volume (3 month) | 2.01K CAD |
| Avg. Daily Volume (10-Days) | 0 CAD |
| Shares Outstanding | 74.76M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 90.07% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:32.5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -173.80% |
| Return on Equity (ttm) | -498.21% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2621789 CAD |
| Net Income Avi to Common (ttm) | -2651175 CAD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.14K CAD |
| Total Cash Per Share (mrq) | 0 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.062 |
| Book Value Per Share (mrq) | -0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1699594 CAD |
| Levered Free Cash Flow (ttm) | -515278 CAD |
Profile of Biomind Labs Inc.
| Country | Canada |
| State | N/A |
| City | Canelones |
| Address | Building Ceibo Of. 002 |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.biomindlabs.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammatory disorders, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.
Q&A For Biomind Labs Inc. Stock
What is a current BMND.NE stock price?
Biomind Labs Inc. BMND.NE stock price today per share is 0.38 CAD.
How to purchase Biomind Labs Inc. stock?
You can buy BMND.NE shares on the Cboe CA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biomind Labs Inc.?
The stock symbol or ticker of Biomind Labs Inc. is BMND.NE.
Which industry does the Biomind Labs Inc. company belong to?
The Biomind Labs Inc. industry is Biotechnology.
How many shares does Biomind Labs Inc. have in circulation?
The max supply of Biomind Labs Inc. shares is 74.76M.
What is Biomind Labs Inc. Price to Earnings Ratio (PE Ratio)?
Biomind Labs Inc. PE Ratio is now.
What was Biomind Labs Inc. earnings per share over the trailing 12 months (TTM)?
Biomind Labs Inc. EPS is -0.04 CAD over the trailing 12 months.
Which sector does the Biomind Labs Inc. company belong to?
The Biomind Labs Inc. sector is Healthcare.